NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Elevian

Elevian

Private
Newton, MassachusettsHealthcare & Life Scienceshttps://www.elevian.com/

Last Round

Series A

Sep 16, 2021

Est. Valuation

$100M

Total Funding Raised

$45.5M

Company Overview

Elevian is a biotechnology company that develops regenerative medicines aimed at halting and reversing the molecular damage associated with aging by targeting its root causes and enhancing the body's natural repair and regeneration processes to prevent and treat age-related diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

regenerative medicineGDF11longevity biotechage-related diseaserecombinant proteinanti-aging therapydrug discoverybiotechnologyclinical-stage biotechneurodegenerative diseasetherapeutic candidatepreclinical researchlife extension

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Elevian Comparables

Compare Elevian with similar companies based on industry and business-model similarity.

Elevian comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Elevian Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 16, 2021
VC RoundNov 24, 2020
SeedSep 6, 2018

Elevian Investors

Notable investors and investment history

Elevian investors
InvestorRounds
For Good VenturesVC Round
StartXSeed
ArteFin GmbHSeed
Kizoo Technology CapitalVC Round, Seed
Longevity FundVC Round, Seed
BOLD Capital PartnersVC Round, Series A, Seed
Thynk CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 6, 2018

    $5.5M round led by Bold Capital

Elevian Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Elevian Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Elevian's valuation, stock price, and market status.

Firmographic Details

HeadquartersNewton, Massachusetts
Employee Range5
Year Founded2017
Last FundingSep 16, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.